News

illumigene is a simplified new technology platform, based upon loop amplification (LAMP) that makes molecular diagnostic testing possible for any size laboratory. Meridian said that the technology is

Cambrex said that after the transaction, the business will be renamed Cambrex IEP and will remain in Wiesbaden, Germany. Steven Klosk, president and CEO of Cambrex, said: “In

Melphalan is an FDA-approved chemotherapy for the palliative treatment of multiple myeloma marketed under the brand name Alkeran by GlaxoSmithKline. CyDex said that the trial will compare the

Wedgewood said that the single-use vial packaging will be easier for dentists and their patients to use than the previous multi-dose bottle, a cotton-tipped applicator is dipped into

The investment is expected to enable SAFC Hitech to strengthen its position as a supplier of TMG and satisfy the growing demand for the material in the production

Cellceutix said that Kevetrin is being developed to treat drug resistant cancers. The company has recently reported that Kevetrin showed greater tumor shrinkage than standard therapies in animal

DSM Biomedical said that the expansion is to support the growing demand for its portfolio of polyurethanes for chronically implanted medical devices in the regions. Earlier, DSM Biomedical

Under the three-year research plan, BioSeek will apply its BioMAP platform in an exclusive collaboration centered on a specific drug target class designated by Ono, performing phenotypic screening

Clinical evidence demonstrated that one day of unprotected sun exposure can lead to irreversible cell damage, which is associated with both morphological and histological changes. These changes can